Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Dreyling

Showing results (231-240 of 337) with videos related to

Pageof 34
Sort By:
British Journal of Haematology|November 20, 2008
GeneChip analyses point to novel pathogenetic mechanisms in mantle cell lymphomaInga Vater, Florian Wagner, Markus Kreuz, et al.
International Journal of Cancer|July 9, 2020
The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trialTobias Roider, Xi Wang, Katrin Hüttl, et al.
The New England Journal of Medicine|March 29, 2018
Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell LymphomaConstantine S Tam, Mary Ann Anderson, Christiane Pott, et al.
Blood|December 14, 2004
Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL NetworkMartin Dreyling, Georg Lenz, Eva Hoster, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2019
Long-term in vivo microscopy of CAR T cell dynamics during eradication of CNS lymphoma in miceMatthias Mulazzani, Simon P Fräßle, Iven von Mücke-Heim, et al.
Haematologica|December 26, 2015
Minimal residual disease monitoring by 8-color flow cytometry in mantle cell lymphoma: an EU-MCL and LYSA studyMorgane Cheminant, Coralie Derrieux, Aurore Touzart, et al.
Blood|October 27, 2007
A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphomaEva Hoster, Martin Dreyling, Wolfram Klapper, et al.
Hemasphere|December 8, 2022
First-line Treatment With Bendamustine and Rituximab for Old and Frail Patients With Aggressive Lymphoma: Results of the B-R-ENDA TrialFriederike Braulke, Florian Zettl, Marita Ziepert, et al.
Hemasphere|February 20, 2020
Mantle Cell Lymphoma of Mucosa-Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network StudyLucia Morello, Sara Rattotti, Laura Giordano, et al.
Leukemia & Lymphoma|October 2, 2012
Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma NetworkMartin Dreyling, Hanneke C Kluin-Nelemans, Sílvia Beà, et al.
Pageof 34

Showing results (231-240 of 337) with videos related to

Sort By:
Pageof 34
British Journal of Haematology|November 20, 2008
GeneChip analyses point to novel pathogenetic mechanisms in mantle cell lymphomaInga Vater, Florian Wagner, Markus Kreuz, et al.
International Journal of Cancer|July 9, 2020
The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trialTobias Roider, Xi Wang, Katrin Hüttl, et al.
The New England Journal of Medicine|March 29, 2018
Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell LymphomaConstantine S Tam, Mary Ann Anderson, Christiane Pott, et al.
Blood|December 14, 2004
Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL NetworkMartin Dreyling, Georg Lenz, Eva Hoster, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2019
Long-term in vivo microscopy of CAR T cell dynamics during eradication of CNS lymphoma in miceMatthias Mulazzani, Simon P Fräßle, Iven von Mücke-Heim, et al.
Haematologica|December 26, 2015
Minimal residual disease monitoring by 8-color flow cytometry in mantle cell lymphoma: an EU-MCL and LYSA studyMorgane Cheminant, Coralie Derrieux, Aurore Touzart, et al.
Blood|October 27, 2007
A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphomaEva Hoster, Martin Dreyling, Wolfram Klapper, et al.
Hemasphere|December 8, 2022
First-line Treatment With Bendamustine and Rituximab for Old and Frail Patients With Aggressive Lymphoma: Results of the B-R-ENDA TrialFriederike Braulke, Florian Zettl, Marita Ziepert, et al.
Hemasphere|February 20, 2020
Mantle Cell Lymphoma of Mucosa-Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network StudyLucia Morello, Sara Rattotti, Laura Giordano, et al.
Leukemia & Lymphoma|October 2, 2012
Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma NetworkMartin Dreyling, Hanneke C Kluin-Nelemans, Sílvia Beà, et al.
Pageof 34